cbdMD (YCBD) E10: $-302.79 (As of Mar. 2026)


YCBD cbdMD Inc YCBD
38 GF Score
Price $0.71
GF Value $0.16
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is cbdMD E10?

cbdMD YCBD +0.57% 38 E10 is $-302.79 as of Mar. 2026. GuruFocus rates YCBD with a GF Score™ of 38/100 and a GF Value™ of $0.16 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

cbdMD's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-302.79 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-26), cbdMD's current stock price is $0.707. cbdMD's E10 for the quarter that ended in Mar. 2026 was $-302.79. cbdMD's Shiller PE Ratio of today is .


cbdMD  (AMEX:YCBD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


cbdMD E10 Related Terms


cbdMD E10 Historical Data

* Premium members only.

The historical data trend for cbdMD's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

cbdMD E10 Chart

cbdMD Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

cbdMD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -304.75 -302.79

YCBD vs SXTC, CABR, CVSI: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, cbdMD's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


cbdMD Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, cbdMD's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where cbdMD's Shiller PE Ratio falls into.


YCBD
38GF Score
cbdMD Inc YCBD
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

cbdMD E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, cbdMD's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.08/330.2130*330.2130
=-0.080

Current CPI (Mar. 2026) = 330.2130.

cbdMD Quarterly Data

per share eps CPI Adj_EPS
201606 -92.670 241.018 -126.965
201609 -79.260 241.428 -108.408
201612 -48.735 241.432 -66.656
201703 -42.648 243.801 -57.764
201706 -16.183 244.955 -21.816
201709 -16.257 246.819 -21.750
201712 -57.600 246.524 -77.154
201803 61.200 249.554 80.981
201806 10.800 251.989 14.153
201809 -40.742 252.439 -53.294
201812 -75.600 251.233 -99.366
201903 -1,126.800 254.202 -1,463.734
201906 -428.400 256.143 -552.282
201909 145.097 256.759 186.607
201912 162.000 256.974 208.171
202003 144.000 258.115 184.223
202006 -64.800 257.797 -83.003
202009 -61.200 260.280 -77.643
202012 -64.800 260.474 -82.149
202103 -86.400 264.877 -107.712
202106 7.200 271.696 8.751
202109 -25.200 274.310 -30.336
202112 -126.000 278.802 -149.234
202203 -34.560 287.504 -39.694
202206 -198.480 296.311 -221.189
202209 -91.120 296.808 -101.375
202212 -29.600 296.797 -32.933
202303 -13.920 301.836 -15.229
202306 -9.280 305.109 -10.044
202309 -72.480 307.789 -77.761
202312 -5.360 306.746 -5.770
202403 -10.840 312.332 -11.461
202406 -8.930 314.175 -9.386
202409 -2.346 315.301 -2.457
202412 -1.730 315.605 -1.810
202503 -1.900 319.799 -1.962
202506 -0.210 322.561 -0.215
202509 -0.076 324.800 -0.077
202512 -0.040 324.054 -0.041
202603 -0.080 330.213 -0.080

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-302.79 mean?
cbdMD (YCBD) has a E10 of $-302.79 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on cbdMD and its competitors.
Is cbdMD's E10 too high?
cbdMD's current E10 is $-302.79. Overall, cbdMD has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does cbdMD's E10 compare to SXTC and CABR?
cbdMD's E10 of $-302.79 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on cbdMD and its competitors. cbdMD's current E10 is $-302.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is cbdMD stock overvalued right now?
Based on GuruFocus' analysis, cbdMD (YCBD) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.16, compared to a current price of $0.71 — trading 341.9% above its estimated fair value. The current E10 is $-302.79. cbdMD's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For cbdMD (YCBD), the current E10 is $-302.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is cbdMD (YCBD) Overvalued in 2026?

Based on GuruFocus' analysis, cbdMD stock appears to be overvalued. The current stock price of $0.71 is trading 341.9% above its estimated GF Value™ of $0.16. GuruFocus considers cbdMD to be Significantly Overvalued.

Key valuation signals for YCBD:

  • E10: $-302.79
  • GF Value™: $0.16 vs. price of $0.71 (341.9% above fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the YCBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


cbdMD Business Description

Address 2101 Westinghouse Boulevard, Suite A, Charlotte, NC, USA, 28273
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
38GF Score

Get the complete analysis for YCBD

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.71
Price
$0.16
GF Value